DexCom, Inc.
DXCMNASDAQ
Product information
What is DexCom, Inc. (DXCM)?
DexCom, Inc. is a medical technology company headquartered in San Diego, California, and was founded in 1999. Its shares trade on Nasdaq under the ticker DXCM. The company is included in the Nasdaq-100 and in the S&P 500.
DexCom makes continuous glucose monitoring (CGM) systems for people living with diabetes. A small sensor worn on the arm or abdomen measures glucose levels under the skin, and the data is sent through a transmitter to a smartphone, a smartwatch or a dedicated receiver. This lets users see their readings and trends without frequent finger-stick blood tests. The systems also work together with some insulin pumps and smart insulin pens. The company also offers a glucose biosensor called Stelo for people without diabetes.
Insurance coverage of the products, growth in the number of users and the approval processes for new devices are among the main subjects that affect the results of companies in this field. The Lzzo.com page for DXCM presents the price in US dollars, its trading currency, together with a price chart and technical indicators.
Sources: dexcom.com, investors.dexcom.com, sec.gov
- Name
- DexCom, Inc.
- Symbol
- DXCM
- Market
- Stocks
What to look for in the technical analysis of DexCom, Inc.
Moving averages help assess the trend and RSI helps assess momentum. Indicators are calculated from real history; when there is not enough history or the required candle fields are missing, the indicator is not calculated. Past results do not guarantee future performance.
Technical indicators
Calculated from observed daily candles (at least 201 observations). No intraday indicators. Indicators are descriptive, not a buy/sell recommendation.
Investment Return CalculatorWith observed closes over the past year
Loading historical prices…